Ebola and the New Politics of Global Health Cooperation

In recent months, two disease outbreaks have captured the attention of the global health community. One is a rapidly expanding Ebola outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo, which was declared a public health emergency of international concern in May 2026. The other is a multi-country outbreak of Andes hantavirus in April 2026, linked to an expedition cruise ship. It triggered an unusually large international contact-tracing effort spanning dozens of countries.

The outbreaks vary widely in scale and severity. As of June 28, Ebola has caused 1,328 confirmed infections and 379 deaths. The hantavirus outbreak has involved 13 cases and remains contained. Yet both demonstrate the same reality: Infectious diseases do not respect borders. They spread through travel, trade, migration, and human interaction, and they create risks that no country can manage alone.

These outbreaks also arrive at a moment when governments are engaged in a consequential debate about the future of global health cooperation. At the 79th World Health Assembly, Member States agreed to extend negotiations on the Pathogen Access and Benefit Sharing (PABS) system and launched a new process to examine reforms to the global health architecture (GHA). At first glance, these discussions appear distinct. One focuses on pathogen samples, genetic sequence data, and access to medical countermeasures; the other, on institutions, governance, and coordination. Yet both are grappling with the same fundamental question: What should international health cooperation look like in an increasingly multipolar world?

The Ebola outbreak offers a useful lens to consider this question.

A Pressure Test for Global Health Cooperation

The tools needed to control Ebola are well understood: Surveillance systems must detect cases quickly; laboratories must confirm diagnoses; and public health teams must trace contacts, isolate cases, engage communities, and implement infection prevention and control measures. Although there are currently no effective vaccines, treatments, or rapid diagnostic tests for the Bundibugyo virus, when the appropriate tools become available, they have to be deployed rapidly through deep partnerships with communities. The challenge is organizing the political, financial, and operational capacities needed to do this work at speed and at scale.

As the Ebola outbreak in Congo has expanded, it has exemplified the central themes countries are debating in Geneva. Governments increasingly want stronger national ownership of health systems and stronger regional capacity to prevent and respond to emergencies. However, outbreaks of this magnitude still require international coordination, technical expertise, financing, and surge support. The debate about how this cooperation should be organized –– the distribution of responsibilities, resources, and benefits –– sits at the heart of both the PABS and GHA discussions.

Much of the public conversation surrounding these efforts has focused on governance arrangements, financing mechanisms, legal frameworks, and implementation timelines. Beneath this technical language lies a broader discussion about sovereignty and interdependence.

The Real Debate

Most countries recognize that modern health threats require collective action. Striking the right balance between interdependence and sovereignty is a longstanding issue in global health governance.

During COVID-19, many countries rapidly shared pathogen samples and data, but found themselves at the back of the queue when vaccines, diagnostics, and treatments became available. As a result, pathogen samples and genetic sequence data have become entwined with broader questions around national agency and negotiating power. For many countries, pathogen sharing is no longer viewed solely as a contribution to global solidarity. It is increasingly considered an expression of sovereignty and an asset that should generate more equitable benefits.

Another point of convergence in the PABS and GHA processes concerns decentralization, driven by the idea that public health decisions should always be made at the most local or immediate level possible. This aspiration is reflected in calls for stronger regional manufacturing of medical countermeasures, more geographically distributed research and development, and greater scientific capacity, including in countries that contribute pathogen samples and genetic sequence data.

From Global Coordination to Local Ownership

The new emphasis on local and regional ownership as the organizing principle of global health is also shaping conversations about the role of international institutions. Member States still regard the World Health Organization (WHO) as the world’s leading source of technical guidance, normative standards, and political convening. Some countries, however, would like to see WHO move away from the operational role it has gradually taken on over the past decade, preferring to strengthen regional and national actors so they can lead on implementation and operational delivery.

The Ebola response illustrates the complexity of this transition. In resource-constrained settings, the distinction between normative and operational functions can become blurred. Outbreaks test assumptions about how international organizations can support regions and countries without displacing national ownership.

The focus on local capacities is closely linked to ongoing discussions on domestic resource mobilization and sustainable financing. The era of large-scale development aid is ending, and much of the GHA process focuses on ensuring that countries can continue to make and sustain progress despite fewer external resources. In many respects, PABS is a debate about how countries should be compensated for participating in a global system that depends on the rapid sharing of pathogen samples and genetic sequence data. Ultimately, the central question underpinning both debates becomes: How can countries exercise greater agency and self-reliance while still accessing the external resources, technology, and investment needed to strengthen health systems and response capacities?

As traditional aid models evolve, countries are increasingly seeking forms of cooperation that provide financial support as well as greater influence over how resources, risks, and benefits are shared.

The Long Arc of Reform

Taken together, these themes suggest that the debates unfolding in Geneva are about much more than the mechanics of global health cooperation. The ambitions expressed in the PABS negotiations and GHA deliberations extend well beyond the health sector, requiring coherence in trade policy, intellectual property, technology transfer, and long-term financing. These are not challenges that health ministries can solve alone in months or years. They are long-term political projects measured in decades. The debates underway in Geneva are ultimately about how countries understand interdependence in a world characterized by shifting power dynamics, growing regional capacity, and competing political priorities.

The path forward will not be straightforward. Despite difficult negotiations and competing interests, countries continue to engage in the process. They are not rejecting interdependence. Instead, they are renegotiating its terms. If the current deliberations succeed in building greater trust, stronger regional capacity, and more equitable cooperation, they may ultimately be remembered as an important inflection point in global health governance.